Department of Neurosurgery, Clínica Universidad de Navarra, C/Pio XII 36, 31008, Pamplona, Navarra, Spain.
Acta Neurochir (Wien). 2012 Nov;154(11):1997-2002; discussion 2002. doi: 10.1007/s00701-012-1475-1. Epub 2012 Aug 29.
The meaning of the ventricular wall fluorescence during 5-aminolevulinic (5-ALA)-guided surgery in patients with glioblastoma (GBM) is still unknown. The authors studied the association between ventricle fluorescence, clinical outcome and survival, and described the histopathological findings of selective biopsies from the ventricular wall.
One hundred and forty patients diagnosed of GBM underwent fluorescence-guided surgery (FGS); 65 of them were naive GBM and ventricle fluorescence during surgery was annotated prospectively. Selective biopsies were collected from the ventricular wall when possible. Clinical and radiological data were registered, including age, Karnofsky Performance Scale (KPS) score, presence of hydrocephalus, overall survival (OS), tumour volume and location (periventricular vs non-periventricular) and leptomeningeal dissemination.
During FGS the ventricle wall was opened just when the tumour was periventricular in the preoperative MRI (45 out of 65). In 28 of them (60 %) the fluorescence extended far away from the site of opening, while in 17 it ended just in the few millimetres around the tumour. All four patients who developed hydrocephalus had periventricular tumours and the ventricle wall had been opened during surgery. Statistically significant differences were seen in OS according to periventricular location (15 m vs 33 m, P = 0.008 log rank). However, there was not significant relationship between ventricle fluorescence and hydrocephalus (P = 0.75), nor survival (14 m vs 15.5 m, P = 0.64).
Preoperative MRI predicts if the ventricle will be opened using the 5-ALA fluorescence, according to tumour location. It does not predict, however if the ventricle wall is going to be fluorescent or not. The fluorescence of the ventricle wall is not a predictor for complications or survival. Periventricular tumour location is an independent bad prognostic factor in GBM.
在接受 5-氨基酮戊酸(5-ALA)引导手术的胶质母细胞瘤(GBM)患者中,心室壁荧光的意义仍不清楚。作者研究了心室壁荧光与临床结果和生存之间的关系,并描述了从心室壁选择性活检的组织病理学发现。
140 名被诊断为 GBM 的患者接受了荧光引导手术(FGS);其中 65 名是初治 GBM,手术期间的心室壁荧光被前瞻性注释。当可能时,从心室壁采集了选择性活检。登记了临床和影像学数据,包括年龄、卡诺夫斯基表现量表(KPS)评分、脑积水的存在、总生存(OS)、肿瘤体积和位置(脑室周围与非脑室周围)以及软脑膜播散。
在 FGS 期间,当术前 MRI 显示肿瘤位于脑室周围时,仅打开心室壁(65 例中有 45 例)。在其中 28 例(60%)中,荧光从打开的部位远远延伸,而在 17 例中,荧光仅在肿瘤周围的几毫米处结束。所有 4 例发生脑积水的患者均有脑室周围肿瘤,且在手术中打开了脑室壁。根据脑室周围位置,OS 存在统计学显著差异(15m 比 33m,P=0.008 log rank)。然而,脑室壁荧光与脑积水之间没有显著关系(P=0.75),也与生存无关(14m 比 15.5m,P=0.64)。
术前 MRI 根据肿瘤位置预测脑室是否会通过 5-ALA 荧光打开。然而,它不能预测脑室壁是否会出现荧光。心室壁荧光不是并发症或生存的预测因素。脑室周围肿瘤位置是 GBM 的一个独立不良预后因素。